FindTrial
Sign In

To Assess the of efficacy of injectable Hyaluronic Acid filler in augmentation of peri-implant soft tissue.

Assessment of efficacy of an injectable Hyaluronic Acid filler in augmentation of peri-implant soft tissue.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053517
Enrollment
25
Registered
2023-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K056- Periodontal disease, unspecified

Interventions

Intervention1: INJECTABLE HYALURONIC ACID FILLER: The respective sites i.e soft tissue around the implants will be treated 0.2 ml of HA (20 mg/ml concentration) particle size of 400µm will be injecte

Sponsors

VSPM DCRC Digdoh Hills Hingna Road Nagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Systemically healthy patients 2.Patient with healthy and stable soft tissue architecture 3.Patients with 1 implant placed with functional restoration with keratinized mucosa 4.Patients with thin gingival phenotype 5.Co-operative, motivated and hygiene conscious patients. 6.Peri-implant probing depth 7.No signs of pre-exsisting peri-implantitis.

Exclusion criteria

Exclusion criteria: 1.Patients with systemic diseases that would have influenced bone or soft tissue metabolism 2.Pregnant or lactating females 3.Tobacco smokers 4.Uncontrolled medical conditions precluding elective surgery 5.Untreated periodontal conditions 6.Patients treated with any medication known to cause gingival hyperplasia 7.Drug and alcohol abuse

Design outcomes

Primary

MeasureTime frame
Gingival Augmnetation around peri-implant soft tissue.Timepoint: baseline- 3 months- 6 months—

Secondary

MeasureTime frame
1.Plaque index 2.Gingival index 3.Modified sulcular bleeding index 4.Probing depth (PD) 5.Clinical attachment level (CAL) 6.Gingival thickness (GT) 7.Keratinized Tissue width 8.Interproximal width (IPW) 9.Papillary Recession depth 10. Patient Reported Outcome Measures- VAS score scale. Timepoint: baseline-3 months- 6 months—

Countries

India

Contacts

Public ContactDr Abhay P Kolte

VSPM DCRC HINGNA ROAD DIGDOH HILLS, POLICE NAGAR NAGPUR-440019

drabhaypkolte@gmail.com9011071467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026